The search results focus on antibody structure, classification, and applications in assays or therapeutic contexts. Key findings include:
Antibodies are Y-shaped glycoproteins composed of heavy (H) and light (L) chains, with variable regions (V) and constant regions (C) .
Secondary antibodies are used in assays to detect primary antibodies, often targeting the Fc region to amplify signals .
Therapeutic antibodies like Solanezumab (anti-amyloid β) highlight variable region engineering for specificity .
While no specific data exists for this antibody, its name suggests it could belong to a class of monoclonal antibodies (mAbs) targeting a specific antigen. Based on antibody nomenclature conventions:
SPAC22A12.08c: Likely denotes a clone ID or catalog number.
Antibody: Indicates its function as an immunoglobulin for binding antigens.
| Hypothetical Attribute | Possible Description |
|---|---|
| Class | Likely IgG (most common) or IgM/IgA. |
| Target Antigen | Unknown; could target intracellular proteins, surface markers, or pathogens. |
| Application | Research (e.g., Western blot, IHC), diagnostics, or therapy. |
| Species Reactivity | Human, mouse, or cross-reactive. |
The absence of data on SPAC22A12.08c Antibody in the provided sources highlights potential limitations:
It may not be commercially available or widely studied.
If proprietary, its details might only exist in unpublished reports or patents.
Recent advancements in antibody engineering (e.g., bispecific antibodies, single-domain antibodies) could be relevant but are not reflected here .
To obtain detailed information, the following steps are suggested:
Literature Search: Use PubMed or Google Scholar with terms like "SPAC22A12.08c Antibody" or "SPAC22A12.08c clone".
Vendor Catalogs: Check antibody suppliers (e.g., Bio-Techne, Sino Biological) or institutional repositories.
Patent Databases: Search USPTO or EPO for filings referencing this antibody.
KEGG: spo:SPAC22A12.08c
STRING: 4896.SPAC22A12.08c.1
SPAC22A12.08c is a gene/protein in Schizosaccharomyces pombe (fission yeast) identified with UniProt accession number O13899. While specific function characterization is ongoing, it belongs to a group of proteins found in the widely-used S. pombe strain 972 / ATCC 24843 . Researchers study this protein to understand fundamental cellular processes in fission yeast, which serves as an important model organism for eukaryotic cell biology, particularly for cell cycle regulation and division mechanisms.
The significance of studying SPAC22A12.08c stems from S. pombe's position as one of the simplest eukaryotic genomes (~5100 genes) . As demonstrated in genome reduction studies, understanding individual protein functions contributes to identifying minimal gene sets required for cellular viability under laboratory conditions.
SPAC22A12.08c antibodies can be employed in multiple experimental approaches:
Methanol fixation protocols are particularly effective for S. pombe proteins as outlined in studies of cell wall proteins .
Antibody validation requires multiple approaches to ensure specificity:
Genetic validation: Use a SPAC22A12.08c deletion strain (if viable) or a conditional knockdown strain as a negative control. Genome reduction studies in S. pombe provide protocols for gene deletion that could be adapted .
Protein tagging comparison: Express epitope-tagged SPAC22A12.08c (e.g., HA, FLAG, or GFP tags) and compare localization/expression patterns between the tagged protein detection and antibody detection.
Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry to confirm the identity of the pulled-down protein. Similar approaches were used to validate antibody specificity in studies of S. pombe Sup11p .
Preabsorption control: Incubate the antibody with purified recombinant SPAC22A12.08c protein before immunostaining to block specific binding sites.
Cross-species reactivity assessment: Test the antibody against related proteins in other yeast species to evaluate potential cross-reactivity.
For effective protein extraction from fission yeast for SPAC22A12.08c detection:
Cell wall disruption: Use glass bead lysis in buffer containing:
50 mM Tris-HCl (pH 7.5)
150 mM NaCl
5 mM EDTA
10% glycerol
1% Triton X-100
Protease inhibitor cocktail
Protease protection: Include both serine and cysteine protease inhibitors to prevent degradation during extraction .
When faced with contradictory localization data:
Compare fixation methods: Different fixation methods can significantly affect epitope accessibility. Methanol fixation often preserves different epitopes than paraformaldehyde fixation in S. pombe .
Evaluate antibody specificity under different conditions: Perform immunogold electron microscopy to obtain higher resolution localization data, as used in fission yeast cell wall protein studies .
Cross-validate with tagged proteins: Express fluorescently-tagged SPAC22A12.08c and compare localization with antibody staining.
Cell cycle dependence: Determine if localization varies throughout the cell cycle by synchronizing cultures using methods such as lactose gradient centrifugation or nitrogen starvation release.
Stress response: Test if protein localization changes under different stress conditions (oxidative, temperature, nutrient limitation).
To reduce background and improve signal-to-noise ratio:
Blocking optimization: Test different blocking agents:
5% non-fat dry milk
3-5% BSA
Commercial blocking reagents optimized for yeast samples
Detergent screening: Test multiple detergents in wash buffers:
| Detergent | Concentration | Best For |
|---|---|---|
| Triton X-100 | 0.1-0.3% | Membrane proteins |
| Tween-20 | 0.05-0.1% | General applications |
| SDS | 0.01-0.1% | Stringent washing |
| Saponin | 0.1-0.5% | Preserving membrane structures |
Secondary antibody controls: Include samples with secondary antibody only to identify non-specific binding.
For comprehensive protein interaction analysis:
Proximity labeling approaches: Combine with BioID or APEX2 approaches by fusing promiscuous biotin ligases to SPAC22A12.08c and using the antibody to verify expression and localization.
Cross-linking mass spectrometry: Use formaldehyde or DSS cross-linking followed by immunoprecipitation with SPAC22A12.08c antibody to capture transient interactions.
Yeast two-hybrid validation: Confirm interactions identified through co-IP by independent methods.
Functional validation: Use genetic interaction studies (synthetic lethality, suppressor screens) to validate biological significance of identified interactions.
For accurate protein quantification:
Western blot quantification methodology:
Use internal loading controls (e.g., tubulin, actin)
Employ fluorescent secondary antibodies for wider linear range
Create standard curves using recombinant protein
Utilize image analysis software with background subtraction
Immunohistochemistry with quantitative image analysis:
Similar to approaches used for human tissues , develop quantification methods for intensity and distribution patterns.
Mass spectrometry-based quantification:
Use antibody for immunoprecipitation followed by targeted MS approaches like PRM or SRM.
Epitope masking can occur due to protein-protein interactions, post-translational modifications, or conformational changes:
Epitope retrieval techniques:
Heat-induced epitope retrieval: 10 mM citrate buffer (pH 6.0), 95°C for 20 minutes
Enzymatic retrieval: 0.1% trypsin in PBS for 10-15 minutes at 37°C
Detergent treatment: 0.5% SDS for 5 minutes at room temperature before blocking
Denaturing conditions: For Western blots, compare reducing vs. non-reducing conditions and different detergents.
Cell cycle-dependent modifications: Synchronize cultures to determine if detection varies throughout the cell cycle.
Protein complex dissociation: Use more stringent lysis conditions or competitive elution strategies to disrupt protein complexes that might mask the epitope.
For detecting low abundance proteins:
Signal amplification systems:
| Method | Amplification Factor | Best For |
|---|---|---|
| Tyramide Signal Amplification | 10-100× | Immunofluorescence |
| Poly-HRP conjugated secondaries | 5-20× | Western blot, ELISA |
| Biotin-streptavidin systems | 3-10× | Multiple applications |
| Quantum dots | 5-20× | Fluorescence imaging |
Cell fractionation: Enrich for specific cellular compartments where SPAC22A12.08c may be concentrated.
Optimized immunoprecipitation: Use larger volumes of starting material and optimized antibody concentrations.
Highly sensitive detection methods: Consider using more sensitive detection reagents similar to those used for human antibody characterization .